Aspira Pathlab & Diagnostics Ltd — Important, 26-09-2025: Company Update

Aspira Pathlab & Diagnostics has received a public announcement regarding an open offer to its public shareholders. A group of acquirers, led by Mr. Arvind Karsandas Bhanushali, plans to acquire 26,76,180 equity shares, representing 26% of the company's total paid-up equity. The offer price is Rs. 55 per equity share, valuing the total transaction at approximately 14.72 Cr. This open offer signals a potential shift in the company's ownership structure and control, which is a key development for existing shareholders and could influence future strategic decisions.